An uncommon response to metronomic therapy in a heavily pretreated patient with metastatic carcinosarcoma: a case report.
Debora de Melo GagliatoRudinei Diogo Marques LinckRegis Otaviano Franca BezerraMirela SoutoGabriel Lima LopesGlauco BaiocchiMax Senna ManoPublished in: Journal of medical case reports (2016)
We reviewed the mechanism of action implicated in metronomic chemotherapy, and correlated it with the biology of disease in carcinosarcoma. This information may add to the current literature, providing important insights to future clinical trials in this patient population.